ArticleNature medicine2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The molecular profile of gliomas in adolescents and young adults.Neuro-oncology advances · 2026Review
Corrections and comments
- Erratum for
Authors and funding
42 authors.
Lindsay B KilburnChildren's National Hospital, Washington, DC, USA. lkilburn@childrensnational.org.ORCID http://orcid.org/0000-0003-1478-3619
Dong-Anh Khuong-QuangChildren's Cancer Centre, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0001-6305-7790
Jordan R HansfordMichael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0001-7733-383X
Daniel LandiDuke University, Durham, NC, USA.
Jasper van der LugtPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-8186-338X
Sarah E S LearyCancer and Blood Disorders Center, Seattle Children's, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-0225-6184
Pablo Hernáiz DrieverCharité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, German HIT-LOGGIC-Registry for LGG in Children and Adolescents, Berlin, Germany.ORCID http://orcid.org/0000-0003-3135-3872
Simon BaileyGreat North Children's Hospital and Newcastle University Centre for Cancer, Newcastle-upon-Tyne, UK.ORCID http://orcid.org/0000-0003-4763-4329
Sébastien PerreaultCHU Sainte-Justine, Université de Montréal, Montréal, Quebec, Canada.
Geoffrey McCowageSydney Children's Hospitals Network, Westmead, New South Wales, Australia.
Angela J WaandersAnn & Robert H. Lurie Children's Hospital, Chicago, IL, USA.
David S ZieglerKids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.ORCID http://orcid.org/0000-0001-7451-7916
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Patricia A BaxterTexas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Hyoung Jin KangDepartment of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-1009-6002
Timothy E HassallChildren's Health Queensland Hospital and Health Service, South Brisbane, QLD, Australia.
Jung Woo HanSeverance Hospital, Yonsei University Health System, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0001-8936-1205
Darren HargraveUCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.ORCID http://orcid.org/0000-0001-8219-9807
Andrea T FransonC.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-5361-7683
Michal Yalon OrenPediatric Hemato-Oncology, Sheba Medical Center, Ramat Gan, Israel.
Helen ToledanoDepartment of Pediatric Oncology, Schneider Children's Medical Center, Petach Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Valérie LaroucheDepartment of Pediatrics, Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Quebec City, Quebec, Canada.ORCID http://orcid.org/0000-0003-4082-7267
Cassie KlineDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-7765-7690
Mohamed S AbdelbakiDivision of Hematology and Oncology, Department of Pediatrics, School of Medicine, Washington University, St. Louis, MO, USA.
Nada JabadoMcGill University Health Centre (MUHC), Montreal Children's Hospital (MCH), Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0003-2485-3692
Nicholas G GottardoDepartment of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Australia, and Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID http://orcid.org/0000-0002-1082-6776
Nicolas U GerberDepartment of Oncology, University Children's Hospital, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-1783-631X
Nicholas S WhipplePrimary Children's Hospital and University of Utah, Salt Lake City, UT, USA.
Devorah SegalNYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0002-9740-1286
Susan N ChiPediatric Neuro-Oncology, Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Liat OrenDepartment of Hematology & Oncology, Rambam Healthcare Campus, Haifa, Israel.
Enrica E K TanHaematology/Oncology Service, KK Women's and Children's Hospital, Singapore, Singapore.
Sabine MuellerDepartment of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8216-9357
Izzy CornelioDay One Biopharmaceuticals, Brisbane, CA, USA.
Lisa McLeodDay One Biopharmaceuticals, Brisbane, CA, USA.
Xin ZhaoDay One Biopharmaceuticals, Brisbane, CA, USA.
Ashley WalterDay One Biopharmaceuticals, Brisbane, CA, USA.
Daniel Da CostaDay One Biopharmaceuticals, Brisbane, CA, USA.
Peter ManleyDay One Biopharmaceuticals, Brisbane, CA, USA.
Samuel C BlackmanDay One Biopharmaceuticals, Brisbane, CA, USA.
Roger J PackerDivision of Neurology, Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
Karsten NysomDepartment of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-2935-0058
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.